Exclusive neoadjuvant chemotherapy in locally advanced resectable gastric and gastro-esophageal junction adenocarcinoma

Article Article scientifique Article Exclusive neoadjuvant chemotherapy in locally advanced resectable gastric and gastro-esophageal junction adenocarcinoma eng 2017 author Fernandez Eugenio 509936 author Cacheux Wulfran 817057 author Frossard Jean-Louis 35038 author Kossler Thibaud 500516 author Abou Magali 510786 author Moniez Michael author Huber Olivier 50133 author Puppa Giacomo 795799 author Roth Arnaud 134504 552-556 10.1016/j.dld.2016.12.025 28179095 1590-8658 Perioperative chemotherapy improves the prognosis of patients with locoregionally advanced resectable gastric and gastro-esophageal junction adenocarcinoma. Nevertheless, only 50% of operated patients could receive the postoperative component chemotherapy. An exclusive preoperative chemotherapy is therefore an interesting strategy. We report the clinical course of patients with operable gastric and gastroesophageal junction adenocarcinoma treated with an intention of exclusive preoperative chemotherapy. Dewey 616 Dewey 616.07 137 Département de pathologie et immunologie 21F 56 Département de médecine 221 false 223 Groupe Roth Arnaud (oncologie) 285 335 Pancréatite aiguë 601 Digestive and Liver Disease 49 5 dc10965e-5082-41e1-90d2-bc0a49e9e968 Article (Published version) Restricted Exclusive neoadjuvant .... adenocarcinoma.pdf 607994 application/pdf restrictedAccess Faculté de médecine / Section de médecine fondamentale / Département de pathologie et immunologie Faculté de médecine / Section de médecine clinique / Département de médecine

Title	Published in	Access level	OA Policy	Year	Views	Downloads

Exclusive neoadjuvant chemotherapy in locally advanced resectable gastric and gastro-esophageal junction adenocarcinoma	Digestive and Liver Disease			2017	554	1

Archive ouverte UNIGE

Abou, Magali